Clinical trial
Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain…
NCT00375869 · Royal Alexandra Hospital, Other · Completed
Key facts
| NCT number | NCT00375869 |
|---|---|
| Title | Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury |
| Official title | A Prospective Randomized Placebo Controlled Study of the Efficacy and Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury |
| Lead sponsor | Royal Alexandra Hospital, Other |
| Collaborators | University of Alberta |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | Darbeopoetin, Normal Saline (Placebo) |
| Enrollment | 10 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 13, 2006 |
| Last update posted | Mar 5, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: